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The	American	Heart	Association	defines	cardiac	
arrythmias as any change from the normal sequence of 
electrical impulses. Cardiac arrythmias can be the result 
of either an abnormality of impulse formation [which can 
lead to impulses that are too fast, too slow or irregular] or 
else an abnormality in impulse conduction [which can lead 
to heart block].
During a normal cardiac cycle the electric impulse 
originates in the sino-atrial node (SA node), it then passes 
through the atria where it reaches the atrio-ventricular node 
(AV node) and is then conducted through the ventricles.
When there is a change in the formation of the electrical 
impulse, impulses may be formed in the SA node at a very 
fast or slow rate (sinus tachycardia and sinus bradycardia, 
respectively). Sometimes the electrical impulses start to 
originate from areas in the heart outside the SA node. This 
may either occur occasionally (such as in supraventricular 
ectopic or ventricular ectopic) or else, all electrical impulses 
start to originate from outside the SA node (atrial fibrillation 
or ventricular fibrillation). The former type usually results in 
impulses which follow the baseline sinus rhythm but which are 
too fast or too slow. On the other hand, the latter usually result 
in electrical impulses which arise in a very fast and irregular 
manner. The exceptions to this are junctional rhythm, which 
involves electrical impulses arising from the AV node at a very 
slow and regular rate, and supraventricular tachycardia, which 
involves electrical impulses arising from a site in the atria 
outside the SA node at a fast but regular rate.
When there is a change in electrical impulse 
conduction the result is heart block. 
Heart	block	can	be	classified	as	1st, 2nd or 3rd degree. In 
1st degree heart block there is a delay in the conduction 
of electrical impulse at the AV node. In 2nd degree heart 
block there is intermittent non-conduction of the electrical 
impulses at the AV node. In 3rd degree heart block none 
of the electrical impulses arising in the SA node are 
conducted through the AV node to the ventricles.
Cardiac arrythmias can usually be successfully managed 
with medication, discontinuing any causative drugs or else 
by inserting a pacemaker in the case of heart block. 
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